Title : Casein kinase II inhibition reverses pain hypersensitivity and potentiated spinal N-methyl-D-aspartate receptor activity caused by calcineurin inhibitor.

Pub. Date : 2014 May

PMID : 24610957






2 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Clinically used calcineurin inhibitors, including tacrolimus (FK506) and cyclosporine A, can induce calcineurin inhibitor-induced pain syndrome (CIPS), which is characterized as severe pain and pain hypersensitivity. Tacrolimus calcineurin binding protein 1 Rattus norvegicus
2 Clinically used calcineurin inhibitors, including tacrolimus (FK506) and cyclosporine A, can induce calcineurin inhibitor-induced pain syndrome (CIPS), which is characterized as severe pain and pain hypersensitivity. Tacrolimus calcineurin binding protein 1 Rattus norvegicus